The Drug Enforcement Administration (DEA) has removed a marijuana-based medication from the list of federally controlled substances. GW Pharmaceuticals announced on Monday that Epidiolex, a prescription drug it developed that’s derived from cannabis and used in the treatment of epilepsy, had been taken off Schedule V of the Controlled Substances Act. Effectively immediately, the CBD […]
This post was created with our nice and easy submission form. Create your post!